PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+13.26%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$90.2M
AUM Growth
+$90.2M
(-7%)
Cap. Flow
-$15.9M
Cap. Flow
% of AUM
-17.59%
Top 10 Holdings %
Top 10 Hldgs %
39%
Holding
124
New
13
Increased
18
Reduced
57
Closed
18
Top Buys
| 1 |
Cencora
COR
|
$983K |
| 2 |
Pentair
PNR
|
$795K |
| 3 |
ZAGG
ZAGG Inc Common Stock (Delaware)
ZAGG
|
$602K |
| 4 |
Veritone
VERI
|
$498K |
| 5 |
Plus Therapeutics
PSTV
|
$479K |
Top Sells
| 1 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$2.18M |
| 2 |
NeoGenomics
NEO
|
$1.89M |
| 3 |
ATRS
Antares Pharma, Inc.
ATRS
|
$1.89M |
| 4 |
Tactile Systems Technology
TCMD
|
$1.84M |
| 5 |
Altimmune
ALT
|
$1.5M |
Sector Composition
| 1 | Healthcare | 60.72% |
| 2 | Industrials | 11.67% |
| 3 | Technology | 9.76% |
| 4 | Financials | 3.3% |
| 5 | Communication Services | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Axogen
AXGN
$743M
| $9.29M | 10.31% | 554,792 -37,375 | -6% | -$626K |
|
2
Abbott
ABT
$231B
| $4.02M | 4.46% | 82,710 -836 | -1% | -$40.6K |
|
3
Rockwell Medical
RMTI
$58.9M
| $3.49M | 3.87% | 440,134 -45,299 | -9% | -$359K |
|
4
AtriCure
ATRC
$1.84B
| $3.28M | 3.64% | 135,368 -1,849 | -1% | -$44.8K |
|
|
VYNT
5
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $3.27M | 3.63% | 828,366 -8,542 | -1% | -$33.7K |
|
|
6
NeoGenomics
NEO
$1.13B
| $2.77M | 3.07% | 308,800 -211,475 | -41% | -$1.89M |
|
7
LeMaitre Vascular
LMAT
$2.16B
| $2.66M | 2.95% | 85,250 -23,425 | -22% | -$731K |
|
8
Idexx Laboratories
IDXX
$51.8B
| $2.26M | 2.51% | 14,000 | – | – |
|
|
CSII
9
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.21M | 2.45% | 68,550 -67,500 | -50% | -$2.18M |
|
10
CryoPort
CYRX
$444M
| $1.91M | 2.11% | 387,481 -23,125 | -6% | -$114K |
|
11
Pfizer
PFE
$141B
| $1.75M | 1.94% | 52,184 -1,895 | -4% | -$63.7K |
|
12
Integer Holdings
ITGR
$3.78B
| $1.61M | 1.78% | 37,200 -1,350 | -4% | -$58.4K |
|
13
Eli Lilly
LLY
$657B
| $1.52M | 1.68% | 18,450 -1,750 | -9% | -$144K |
|
|
ZIXI
14
DELISTED
Zix Corporation
ZIXI
| $1.5M | 1.67% | 264,379 -16,510 | -6% | -$93.9K |
|
15
Microsoft
MSFT
$3.77T
| $1.49M | 1.65% | 21,585 -1,225 | -5% | -$84.4K |
|
16
Apyx Medical
APYX
$75.3M
| $1.48M | 1.64% | 599,817 -30,501 | -5% | -$75.4K |
|
17
AbbVie
ABBV
$372B
| $1.43M | 1.58% | 19,650 -25 | -0.1% | -$1.81K |
|
18
AT&T
T
$209B
| $1.22M | 1.35% | 32,312 +2,250 | +7% | +$84.9K |
|
19
Aflac
AFL
$57.2B
| $1.19M | 1.32% | 15,300 -500 | -3% | -$38.9K |
|
20
Altria Group
MO
$113B
| $1.17M | 1.3% | 15,700 -950 | -6% | -$70.7K |
|
|
ENTL
21
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $1.13M | 1.25% | 68,316 +8,299 | +14% | +$137K |
|
22
CVS Health
CVS
$92.8B
| $1.13M | 1.25% | 14,050 -933 | -6% | -$75K |
|
|
CGNT
23
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.12M | 1.25% | 645,303 -190,018 | -23% | -$331K |
|
24
JetBlue
JBLU
$1.95B
| $1.05M | 1.16% | 45,950 +2,200 | +5% | +$50.2K |
|
25
ANI Pharmaceuticals
ANIP
$2.03B
| $1.01M | 1.12% | 21,550 -600 | -3% | -$28.1K |
|